Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose amiodarone versus amiodarone plus magnesium for post-CABG atrial fibrillation
IRCT20141209020258N169Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amiodarone and magnesium in Atrial fibrillation (AFib) (2 arms), sponsored by Arak University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
amiodaronemagnesium
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20141209020258N169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N169.